Search Results 481-490 of 14809 for anti-TNF drugs
Research in the Experimental Therapeutics Program of Mayo Clinic Comprehensive Cancer Center focuses on signaling pathways, anti-cancer drugs, ...
This is an investigational study, also known as LATTICE-CD, of the experimental medication BMS-986165 in participants with moderate to severe Crohn's Disease, a ...
About this study. The investigators goal is to evaluate the role of XOLAIR® in treatment of Acute Tubulointerstitial Nephritis (AIN) with the goal of ...
Lenvatinib is also used in combination with pembrolizumab injection as first-line treatment of advanced renal cell carcinoma (RCC), a kind of kidney cancer, ...
Weigh the potential benefits against the potential risks before taking this medication while breastfeeding. Drug Interactions. Although certain medicines should ...
Male patients who have female partners should use effective birth control during treatment with this medicine and for at least 3 months after the last dose.
... anti-HER2 breast cancer treatment for metastatic disease or have breast cancer that has come back during or within 6 months of completing treatment for ...
Drugs & Supplements A-Z · Health Books · Healthy Living Program · Mayo Clinic ... anti-tumor necrosis factor (TNF)-α agents, integrin inhibitor. Exclusion ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Thanks to generous benefactors, your gift today can have 5X the impact to advance AI innovation at Mayo Clinic.